Forging a position as an innovative player in
infectious disease vaccines and therapies

Home
About
Our Technology
Business Development
- Partner Network
- Licensing Strategy and Available Licenses
Investor Relations
Contact Us
- Corporate directory

BioDiem » » Opal Biosciences Investor Briefing, Sydney 13 July 2015

Opal Biosciences Investor Briefing, Sydney 13 July 2015 July 7, 2015 • Category • Author Name

Opal Biosciences Investor Briefing, Sydney 13 July 2015

Latest News

Half Year Financial Report

May 23, 2025

Half Year Financial Report

Read More
2024 AGM CEO Presentation

December 3, 2024

2024 AGM CEO Presentation

Read More

Join our email list!

Join our email distribution list to be updated with announcements.

© Copyright 2014 BioDiem

Privacy Policy
Terms and conditions